These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6268760)

  • 1. Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.
    Perry RH; Dockray GJ; Dimaline R; Perry EK; Blessed G; Tomlinson BE
    J Neurol Sci; 1981 Sep; 51(3):465-72. PubMed ID: 6268760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.
    Yaksh TL; Abay EO; Go VL
    Brain Res; 1982 Jun; 242(2):279-90. PubMed ID: 6896838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
    Gabriel SM; Davidson M; Haroutunian V; Powchik P; Bierer LM; Purohit DP; Perl DP; Davis KL
    Biol Psychiatry; 1996 Jan; 39(2):82-91. PubMed ID: 8717605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
    Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin (CCK) and vasoactive intestinal peptide (VIP) in the cerebral cortex of the non-hibernating and hibernating golden mantled ground squirrel.
    Bauman WA; Meryn S; Florant GL
    Comp Biochem Physiol A Comp Physiol; 1988; 91(1):179-81. PubMed ID: 2904329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-existence of vasoactive intestinal polypeptide (VIP)- and cholecystokinin (CCK)-like immunoreactivities in thalamocortical neuron in the ventrolateral nucleus of the rat.
    Ogawa R; Itoh K; Kaneko T; Mizuno N
    Brain Res; 1989 Jun; 490(1):152-6. PubMed ID: 2758323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
    Wang JY; Yaksh TL; Go VL
    Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain cholecystokinin and vasoactive intestinal polypeptide: immunoreactivity in rabbits with hepatic coma.
    Meryn S; Bauman WA; Pappas SC; Ferenci P; Jones EA
    Liver; 1986 Oct; 6(5):281-5. PubMed ID: 3784782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.
    Biggins JA; Perry EK; McDermott JR; Smith AI; Perry RH; Edwardson JA
    J Neurol Sci; 1983 Jan; 58(1):117-22. PubMed ID: 6405015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK receptors and human neurological disease.
    Hays SE; Paul SM
    Life Sci; 1982 Jul; 31(4):319-22. PubMed ID: 6292647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex.
    Mazurek MF; Beal MF
    Neurology; 1991 May; 41(5):716-9. PubMed ID: 1674117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential inputs from cholecystokinin-positive neurons to the somatic compartment of parvalbumin-expressing neurons in the mouse primary somatosensory cortex.
    Hioki H; Sohn J; Nakamura H; Okamoto S; Hwang J; Ishida Y; Takahashi M; Kameda H
    Brain Res; 2018 Sep; 1695():18-30. PubMed ID: 29792869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa.
    Harty RF; Pearson PH; Solomon TE; McGuigan JE
    Regul Pept; 1991 Oct; 36(1):141-50. PubMed ID: 1796180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vasoactive intestinal polypeptide (VIP) containing neurones in the rat brain.
    Emson PC; Gilbert RF; Loren I; Fahrenkrug J; Sundler F; Schaffalitzky de Muckadell OB
    Brain Res; 1979 Nov; 177(3):437-44. PubMed ID: 387178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional observations on cholecystokinin and the vasoactive intestinal polypeptide.
    Mutt V
    Peptides; 1981; 2 Suppl 2():209-14. PubMed ID: 6283492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of motilin, cholecystokinin and vasoactive intestinal peptide immunoreactivity in the forebrain and hindbrain of the rat, as determined by radioimmunoassay.
    Beinfeld MC; Korchak DM; Nilaver G; O'Dorisio TM
    Brain Res; 1983 Oct; 312(1):146-50. PubMed ID: 6652504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptide (VIP) inhibits potassium-induced release of cholecystokinin (CCK) from rat caudato-putamen but not from cerebral cortex.
    Allard LR; Beinfeld MC
    Neuropeptides; 1986 Oct; 8(3):287-93. PubMed ID: 3785588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease.
    Gabriel SM; Bierer LM; Davidson M; Purohit DP; Perl DP; Harotunian V
    J Neurochem; 1994 Apr; 62(4):1516-23. PubMed ID: 7510783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
    Ryan JP; Ryave S
    Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.
    Hang CH; Shi JX; Li JS; Wu W; Li WQ; Yin HX
    World J Gastroenterol; 2004 Mar; 10(6):875-80. PubMed ID: 15040036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.